
Small but mighty: small molecules account for about 60% of approved drugs in the U.S. Learn the basics of manufacturing a small molecule and how, against a backdrop of increasingly complex manufacturing routes and formulations, manufacturers are competing globally on price and quality while seeking to improve energy usage, reduce environmental impact, and adopt novel manufacturing technologies. Regulatory advances and geopolitics are also driving innovation. These traditional backbones of the pharma industry have taken a back seat in their visibility with the rise of more exciting therapies, but continue to deliver cutting-edge therapies across a wide range of indications.




